Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
7 participants
INTERVENTIONAL
2019-06-01
2020-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
An experimental, analytical and prospective study will be carried out in which eight fresh adult human cadavers will be selected and injected with 20 ml of 0.01% methylene blue solution at L4 level. The injection will be performed with a Quincke 20G 100-150mm ultrasound-guided needle with a low-frequency curvilinear transducer (4-8 MHz - SonoSite) in the plane between the transverse process of L4 and the spinal erector muscle, bilaterally in each cadaver. by the same operator. After injection of the solution, the cadavers will be submitted to posterior lumbar region dissection by an anatomist and analyzed the dispersion and impregnation of the blue solution.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Erector Spinae vs Fascia Iliaca Block in Hip Arthroplasty
NCT03860324
Erector Spinae Plane (ESP) Block Volunteer Study
NCT04401007
Comparison Between 2 Techniques for Lumbar-ESPB
NCT07104097
Erector Spinae Block Versus PENG Block for Hip Replacement
NCT05796804
PENG vs. QLB vs. Lumbar ESPB in Total Hip Surgery
NCT05600244
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Erector spinae plane block (ESP block) was first described by Forero et al for the treatment of neuropathic chest pain, in which anesthetic is injected between the spinal erector muscle and the transverse vertebral process in the thoracic region, and in theory, it tends to spread to the anterior paravertebral space, to some vertebral spaces above and below the injection site. However, its mechanism of action and exact local anesthetic dispersion have not yet been fully explained clearly.
Such blockade, first described for neuropathic chest pain and later expanded for thoracic and abdominal surgery, has shown other applicability, such as cardiac and breast surgeries.
Forero et al published in July 2018 a study to anatomically demonstrate, from cadaver dissection, the dispersion of dye injected into the same ESP block target at different thoracic levels. They showed the dispersion of methylene blue to the anterior paravertebral space at the injection level in all cadavers, with variable cerebrospinal flow dispersion. In addition there was lateral and medial dispersion to the puncture site, for intercostal spaces, paravertebral sympathetic chain and parietal pleura. However, there are no studies regarding lumbar erector spinae plane block (LESP block) block.
Since 1960 total hip arthroplasty has become one of the most frequent surgeries in the world, due to its technical revolution with improved quality of life of patients with osteoarthritis, rheumatoid arthritis and proximal femur fractures, for example. However, it is a surgery with high postoperative pain potential, and more attention should be paid to postoperative analgesia, since patients undergoing this type of surgery are usually older patients with multiple comorbidities, more sensitive to adverse effects of systemic analgesic drugs (anti-inflammatory drugs, opioids). In addition, pain may lead to hypomobility, which increases the risk of thromboembolic complications.
There are multiple forms of postoperative analgesia for total hip arthroplasty, such as subarachnoid morphine, femoral, obturator and lateral femoral cutaneous nerve block, lumbar plexus block, continuous epidural block, and "3 in 1" block, for example. still considered as the gold standard analgesia for such surgery, intrathecal morphine has some adverse effects as burden: pruritus, urinary retention, nausea and vomiting.The "3 in 1" block has a considerable incidence of partial failure, despite being an unique injection block. Blockade of the lateral femoral obturator, obturator, and nerve nerves requires 3 injections and a larger volume of local anesthetic.The epidural technique has the advantage of allowing the use of a long-term epidural catheter, with or without an analgesia-controlled device. (PCA), but in these more fragile patients with multiple comorbidities it may lead to hypotension or limited ambulation due to concomitant use of anticoagulant medications. Lumbar plexus block is a deep block, with greater risk of complications (retroperitoneal hematoma, deep bleeding), of greater technical difficulty, and erratic local anesthetic dispersion.
The LESP block emerged, based on the same principle as the ESP block in the thoracic region. So far, to the best of our knowledge, there are only a few case reports that evidence its use for hip surgery analgesia. It has potential advantages: ease of execution, low risk of nerve damage and safety in patients with coagulopathies or on anticoagulants. In our service, the investigators have 01 case report presented as a free theme in congress that also describes a good individual effectiveness .
Recent reports have demonstrated lumbar-level ESP block (LESP) for hip and proximal femur surgery, showing good results in postoperative pain control. One of the first works on lumbar ESP block was a letter to the editor in Tulgar et al's Journal of Clinical Anesthesia, which then began a trial comparing LESP with lumbar square, a work still in progress.
With the growing interest of anesthesiologists in ESP block, several studies and case reports have been written in different blockade applications, but the literature lacks cadaveric studies to demonstrate more clearly the local anesthetic dispersion and anatomically justify its clinical effectiveness. .
2. BACKGROUND Hip and proximal femur surgeries usually present with significant postoperative pain, which may hinder patient movement and physiotherapy in the postoperative period, besides immobility predisposing to the development of deep vein thrombosis.
There are several ways of postoperative analgesia for this type of surgery, each having its benefits and harms in relation to the other. This project aims to study the local anesthetic dispersion in the blockade of the lumbar spine erector plane, in order to apply it more safely and effectively as a new modality of analgesia for the hip and proximal femur.
3. OBJECTIVES 3.1. Primary objective The aim of this cadaveric study is to demonstrate the dispersion of methylene blue dye solution when injected into the same anatomical space targeted by the LESP block by anatomical dissection of the lumbar region of cadavers.
4. HYPOTHESIS Lumbar erector spinae plane block (LESP) may provide effective postoperative analgesia for hip and proximal femur surgery, comparable to other existing analgesic modalities. A possible explanation for this is the local anesthetic dispersion injected by this technique, which possibly reaches the posterior lumbar plexus branches.
5. METHODS 5.1 Type of study and scenario An experimental, analytical and prospective study will be conducted at the Capital Death Verification Service (SVOC) and at the Human Anatomy Discipline Laboratory of the University of São Paulo School of Medicine. After approval by the Research Ethics Committee of the School of Medicine of the University of São Paulo, the inclusion of subjects for the study will be initiated.
5.2 Inclusion and exclusion criteria Fresh cadavers, age\> 18 years, height between 150cm and 190cm, any gender will be included.
Corpses with severe spinal deformity, known history of lumbar spine surgery, scars suggestive of large anatomical manipulations of the lumbar region, and corpses with BMI\> 35 kg / m² will be excluded.
5.3 Sample Calculation Eight cadavers will be used, with injections of solutions simulating the LESP block, bilaterally, totaling 16 injections and dissections.
5.4 Experimental Design 20ml of 0.01% methylene blue solution (50mg of methylene blue diluted in 0.9% saline 500ml) will be injected, simulating the LESP block technique: injection between the transverse process of the fourth lumbar vertebra (L4) and the erector muscle of the underlying spine.
The injection will be performed with a Quincke 20G 100-150mm ultrasound-guided needle with a low-frequency curvilinear transducer (4-8 MHz - SonoSite) in the plane between the transverse process of L4 and the spinal erector muscle, bilaterally in each cadaver. by the same operator.
After injection of the solution the cadavers will be submitted to posterior lumbar region dissection by an anatomist and analyzed the dispersion and impregnation of the blue solution. The anatomical structures with the dye dispersion will be photographed and stored.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cadavers
20ml of 0.01% methylene blue solution (50mg of methylene blue diluted in 0.9% saline 500ml) will be injected, simulating the LESP block technique: injection between the transverse process of the fourth lumbar vertebra (L4) and the erector muscle of the underlying spine.
The injection will be performed with a Quincke 20G 100-150mm ultrasound-guided needle with a low-frequency curvilinear transducer (4-8 MHz - SonoSite) in the plane between the transverse process of L4 and the spinal erector muscle, bilaterally in each cadaver. by the same operator.
After injection of the solution the cadavers will be submitted to posterior lumbar region dissection by an anatomist and analyzed the dispersion and impregnation of the blue solution. The anatomical structures with the dye dispersion will be photographed and stored.
Lumbar erector spinae plane block
Injection of blue solution in the erector spinae plane in L4 ultrasound-guided and posterior dissection of the lumbar region.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lumbar erector spinae plane block
Injection of blue solution in the erector spinae plane in L4 ultrasound-guided and posterior dissection of the lumbar region.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age\> 18 years;
* Height between 150cm and 190cm;
* Any gender.
Exclusion Criteria
* Known history of lumbar spine surgery;
* Scars suggestive of large anatomical manipulations of the lumbar region;
* Corpses with BMI\> 35 kg / m².
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joaquim Vieira
Role: STUDY_DIRECTOR
Faculdade de Medicina da Universidade de São Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculdade de Medicina da Universidade de São Paulo
São Paulo, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Vidal E, Gimenez H, Forero M, Fajardo M. Erector spinae plane block: A cadaver study to determine its mechanism of action. Rev Esp Anestesiol Reanim (Engl Ed). 2018 Nov;65(9):514-519. doi: 10.1016/j.redar.2018.07.004. Epub 2018 Aug 27. English, Spanish.
Forero M, Adhikary SD, Lopez H, Tsui C, Chin KJ. The Erector Spinae Plane Block: A Novel Analgesic Technique in Thoracic Neuropathic Pain. Reg Anesth Pain Med. 2016 Sep-Oct;41(5):621-7. doi: 10.1097/AAP.0000000000000451.
Adhikary SD, Pruett A, Forero M, Thiruvenkatarajan V. Erector spinae plane block as an alternative to epidural analgesia for post-operative analgesia following video-assisted thoracoscopic surgery: A case study and a literature review on the spread of local anaesthetic in the erector spinae plane. Indian J Anaesth. 2018 Jan;62(1):75-78. doi: 10.4103/ija.IJA_693_17.
Hamilton DL, Manickam B. The Erector Spinae Plane Block. Reg Anesth Pain Med. 2017 Mar/Apr;42(2):276. doi: 10.1097/AAP.0000000000000565. No abstract available.
Foss NB, Kristensen MT, Palm H, Kehlet H. Postoperative pain after hip fracture is procedure specific. Br J Anaesth. 2009 Jan;102(1):111-6. doi: 10.1093/bja/aen345.
Ibrahim MS, Twaij H, Giebaly DE, Nizam I, Haddad FS. Enhanced recovery in total hip replacement: a clinical review. Bone Joint J. 2013 Dec;95-B(12):1587-94. doi: 10.1302/0301-620X.95B12.31303.
Liang C, Wei J, Cai X, Lin W, Fan Y, Yang F. Efficacy and Safety of 3 Different Anesthesia Techniques Used in Total Hip Arthroplasty. Med Sci Monit. 2017 Aug 2;23:3752-3759. doi: 10.12659/msm.902768.
Kearns RJ, Macfarlane AJ, Anderson KJ, Kinsella J. Intrathecal opioid versus ultrasound guided fascia iliaca plane block for analgesia after primary hip arthroplasty: study protocol for a randomised, blinded, noninferiority controlled trial. Trials. 2011 Feb 21;12:51. doi: 10.1186/1745-6215-12-51.
Kang H, Ha YC, Kim JY, Woo YC, Lee JS, Jang EC. Effectiveness of multimodal pain management after bipolar hemiarthroplasty for hip fracture: a randomized, controlled study. J Bone Joint Surg Am. 2013 Feb 20;95(4):291-6. doi: 10.2106/JBJS.K.01708.
Tulgar S, Senturk O. Ultrasound guided Erector Spinae Plane block at L-4 transverse process level provides effective postoperative analgesia for total hip arthroplasty. J Clin Anesth. 2018 Feb;44:68. doi: 10.1016/j.jclinane.2017.11.006. Epub 2017 Nov 14. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16607219.4.0000.0065
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.